Posts Tagged: pharmaceutical

Opinion

California’s crucial first step in drug-pricing transparency

The drug and vitamin section of a big-box store in Folsom, California. (Photo: Cassiohabib, via Shutterstock)

OPINION: In signing first-in-the-nation legislation to force greater transparency in drug pricing practices, Gov. Brown has signaled the beginning of a new era on controlling health care costs. But more can and should be done to rein in out-of-control drug prices. Drug costs have been increasing by about 10% per year and there are notorious examples of products that have increased by 500%.  Even when insurance pays for medications, the costs always go back to the consumer.

Opinion

Limiting drug firms’ gifts to doctors impedes education

A senior medical practitioner on the phone with hospital records. (Photo: sirtravelalot, via Shutterstock)

OPINION: The California Assembly is currently considering a bill, Senate Bill 790, which would put in place severe restrictions around gifts or other financial benefits that pharmaceutical companies can give to medical professionals as part of marketing activities. Not only will the bill limit physician access to important information about new treatments, but it also insults the integrity of every physician practicing in California and is a threat to the patient-physician relationship.

Opinion

Nurses: Time to cut drug prices

A recent demonstration in support of curtailing drug prices. (Photo: California Nurses Association)

OPINION: The best argument for passing Proposition 61 to cut drug prices in California, may be SB 1010, a modest effort to require the drug manufacturers give more notice and some justification when jacking up prices. Though the bill would not have actually cut prices, it drew ferocious opposition from a who’s who list of major pharmaceutical firms. They won.

Opinion

Costly drugs or access to health care: Should we really have to choose?

A physician flanked by the California flag. (Illustration: Niyazz, via Shutterstock).

OPINION: Prices for prescription drugs are rising precipitously, seriously threatening public and private healthcare budgets, and creating barriers preventing patients from accessing needed therapies. Pharmaceuticals now account for 19 percent of employer spending and Medicare spending on healthcare and, with a slew of approvals of new $100,000+ medications, there is no relief in sight.

Support for Capitol Weekly is Provided by: